When will the FDA reclassify BPC-157 to Category 1?
Before 2027
68.00%
Before November
55.00%
Medicine
Will the FDA approve retatrutide?
Before Jan 1, 2029
99.00%
Before Jul 1, 2028
94.00%
When will Compass Pathways submit a NDA for COMP360 psilocybin?
before April 2027
84.00%
before 2027
80.00%
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
Before 2028
91.00%
Before October 2027
84.00%
Will the FDA approve a cure for Type 1 diabetes before 2033?
3800%
Before 2033
38.00%
$100→$294.12
$100 →$161.29
Will the FDA approve gedatolisib for advanced breast cancer?
Before Jul 1, 2027
84.00%
Before Jan 1, 2027
73.00%
Will the FDA approve cytisinicline for smoking cessation?
Before Jul 1, 2027
48.00%
Before Jan 1, 2027
18.00%
Will the FDA approve camizestrant for advanced breast cancer?
Before Jan 1, 2028
77.00%
Before Jan 1, 2027
66.00%
Will the FDA approve CagriSema?
Before Jul 1, 2027
85.00%
Before Jan 1, 2028
82.00%
When will Intellia Therapeutics submit a BLA for Lonvo-z?
before April 2027
80.00%
before 2027
75.00%